About the Authors

Michel Lecendreux

Contributed equally to this work with: Michel Lecendreux, Guillaume Churlaud

Affiliations AP-HP, Pediatric Sleep Center and National Reference Centre for Orphan Diseases, Narcolepsy, Idiopathic Hypersomnia and Kleine-Levin Syndrome (CNR narcolepsie-hypersomnie), CHU Robert-Debré, Paris, France, Pediatric Sleep Disorders Center, Robert Debré Hospital, Paris, France

Guillaume Churlaud

Contributed equally to this work with: Michel Lecendreux, Guillaume Churlaud

Affiliations AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (I2B), Paris, France, Sorbonne Université, UPMC Univ Paris 06, UMRS 959, Immunology-Immunopathology- Immunotherapy (I3), Paris, France, INSERM, UMR_S 959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France

Fabien Pitoiset

Affiliations AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (I2B), Paris, France, Sorbonne Université, UPMC Univ Paris 06, UMRS 959, Immunology-Immunopathology- Immunotherapy (I3), Paris, France, INSERM, UMR_S 959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France

Armelle Regnault

Affiliation Aviesan/Institut Multi-Organismes Immunologie, Hématologie et Pneumologie (ITMO IHP), Paris, France

Tu Anh Tran

Affiliation Pediatrics department, Centre hospitalo-universitaire de Nîmes, 30029 Nîmes Cedex 9, France. INSERM U1012, Le Kremlin Bicêtre, France

Roland Liblau

Affiliation INSERM UMR1043—CNRS UMR5282—Université Toulouse III, Toulouse, France

David Klatzmann

Affiliations AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (I2B), Paris, France, Sorbonne Université, UPMC Univ Paris 06, UMRS 959, Immunology-Immunopathology- Immunotherapy (I3), Paris, France, INSERM, UMR_S 959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France

Michelle Rosenzwajg

michelle.rosenzwajg@upmc.fr

Affiliations AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (I2B), Paris, France, Sorbonne Université, UPMC Univ Paris 06, UMRS 959, Immunology-Immunopathology- Immunotherapy (I3), Paris, France, INSERM, UMR_S 959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceptualization: MR DK ML RL TT. Funding acquisition: DK. Investigation: ML RL TT GC FP AR. Methodology: MR DK ML RL TT. Project administration: MR DK. Resources: ML RL TT MR DK. Supervision: MR DK. Validation: ML RL TT GC FP AR. Writing – original draft: ML GC MR. Writing – review & editing: ML GC MR.